5.3.3 Diagnostics Moves Out of the Hospital
5.3.4 Disruption Looms
6 PCR Recent Developments
6.1.1 Importance of These Developments
6.1.2 How to Use This Section
6.2 Bio Molecular Systems Gets Approval for Portable PCR Cycler
6.3 Roche Acquires GenMark
6.5 Nuclein Closes $14M in Funding
6.6 WuXi Diagnostics Closes $150M Series B Financing Round
6.7 Visby Medical to develop rapid Flu-COVID PCR test
6.8 Thermo Fisher to acquire Mesa Biotech
6.9 Scope Fluidics Secures €6.2M Supporting Rapid MDx
6.10 SARS- Testing Demand to Continue Through 2022, and Beyond
6.11 Malaria Assays Use CRISPR for Point-of-Care Multispecies Detection
6.12 Fluidigm Saliva Test for SARS-CoV-2 Uses Extraction-free RT-PCR
6.13 Visby Medical Gonorrhea Test Wins $19M AMR Diagnostic Competition
6.14 HelixBind Receives $3M NIH Grant to Expand Infection Dx Platform
4.3.3 Diagnostics Moves Out of the Hospital
4.3.4 Disruption Looms
5. PCR Recent Developments
5.1.1 Importance of These Developments
Scope Fluidics Secures €6.2M Supporting Rapid MDx
Quidel Expects SARS-CoV-2 Testing Demand to Continue Through 2022, and Beyond
Malaria Assays Use CRISPR for Point-of-Care Multispecies Detection
Fluidigm Saliva Test for SARS-CoV-2 Uses Extraction-free RT-PCR
Visby Medical Gonorrhea Test Wins $19M AMR Diagnostic Competition
HelixBind Receives $3M NIH Grant to Expand Bloodstream Infection Dx Platform
Israel s Nucleix Targeting US Market With Noninvasive Bladder, Lung Cancer Assays
Thermo Fisher Sees Many Complementary Offerings in Qiagen Combination
DxTerity Gets CE Mark for At-Home Blood Sample Collection Device
Fetal Cell-Based NIPT by Droplet Digital PCR Demonstrated in Japanese Pilot Study
4.3.3 Diagnostics Moves Out of the Hospital
4.3.4 Disruption Looms
5. PCR Recent Developments
5.1.1 Importance of These Developments
5.1.2 How to Use This Section
Scope Fluidics Secures ?6.2M Supporting Rapid MDx
Quidel Expects SARS-CoV-2 Testing Demand to Continue Through 2022, and Beyond
Malaria Assays Use CRISPR for Point-of-Care Multispecies Detection
Fluidigm Saliva Test for SARS-CoV-2 Uses Extraction-free RT-PCR
Visby Medical Gonorrhea Test Wins $19M AMR Diagnostic Competition
HelixBind Receives $3M NIH Grant to Expand Bloodstream Infection Dx Platform
Israel s Nucleix Targeting US Market With Noninvasive Bladder, Lung Cancer Assays
Thermo Fisher Sees Many Complementary Offerings in Qiagen Combination
DxTerity Gets CE Mark for At-Home Blood Sample Collection Device